Covered recipient · General Payments record
MICHAEL R BRADY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,676.01
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.91 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $119.05 | 1 |
| Acerta Pharma LLC | $62.04 | 3 |
| Abbott Laboratories | $45.65 | 2 |
| Averitas Pharma Inc. | $31.78 | 1 |
| DJO, LLC | $26.39 | 1 |
| Nalu Medical, Inc. | $18.28 | 1 |
| Novo Nordisk AS | $13.95 | 1 |
| Exact Sciences Corporation | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $25.33 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124949608 | CMS |
| Abbott Laboratories | $20.32 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124949612 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104434863 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.43 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105393830 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.70 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104494478 | CMS |
| Averitas Pharma Inc. | $31.78 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133419366 | CMS |
| DJO, LLC | $26.39 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154744032 | CMS |
| Exact Sciences Corporation | $13.77 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114597949 | CMS |
| Medtronic, Inc. | $119.05 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117180517 | CMS |
| Nalu Medical, Inc. | $18.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133995927 | CMS |
| Novo Nordisk Inc | $13.95 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097834722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.